1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [ffea3302-e0a2-4de6-9063-db073eafe1cd] => Array ( [runtime-id] => ffea3302-e0a2-4de6-9063-db073eafe1cd [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [443ba7f3-2536-48db-958c-791a0bdbb586] => Array ( [runtime-id] => 443ba7f3-2536-48db-958c-791a0bdbb586 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;ae7b8ec4d52581ec88826751cb9035eaf5b87f32 ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [ffea3302-e0a2-4de6-9063-db073eafe1cd] => Array ( [runtime-id] => ffea3302-e0a2-4de6-9063-db073eafe1cd [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [443ba7f3-2536-48db-958c-791a0bdbb586] => Array ( [runtime-id] => 443ba7f3-2536-48db-958c-791a0bdbb586 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;ae7b8ec4d52581ec88826751cb9035eaf5b87f32 ) ) )TABLE 1:Clinical and radiologic findings in the two study groups
Ischemic Leukoaraiosis (n = 50) CADASIL (n = 19) Clinical characteristics Age (yr ± SD) 69.8 ± 9.8 (range, 47–86) 47.3 ± 12.2 (range, 21–69) Males 32 (64%) 8 (42%) Hypertension 40 (80%) 1 (5%) Diabetes mellitus 6 (12%) None Anti-platelet therapy 46 (92%) 15 (79%) Anti-coagulant therapy None 2 (10%) Global cognitive function MMSE score 28–30 25 (50%) 16 (84%) MMSE score 24–27 14 (28%) 3 (16%) MMSE score <24 7 (14%) None MR imaging findings Confluent changes (score of 3 on Fazekas scale) 43 (86%) 17 (90%)
Note.—CADASIL indicates cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; MMSE, Mini-Mental State Examination.